SCHEMBL1992191

SCHEMBL1992191

CS(=O)(=O)c1nc2c(c(S(C)(=O)=O)n1)CCC2

nearest known ligand 0.57

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.57
L3MBTL1 Q9Y468 1/20 0.57
ALDH1A1 P00352 4/20 0.43
KDM4E B2RXH2 3/20 0.41
LMNA P02545 2/20 0.40
TP53 P04637 1/20 0.40
POLB P06746 1/20 0.40
MEN1 O00255 2/20 0.38
MAPK1 P28482 2/20 0.38
KMT2A Q03164 2/20 0.38
CYP1A2 P05177 2/20 0.38
CYP2C19 P33261 1/20 0.38
ACHE P22303 2/20 0.35
BPTF Q12830 1/20 0.35
ADRB2 P07550 1/20 0.35
GAA P10253 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
USP2 O75604 1/20 0.33
MAPT P10636 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1991256 0.96 SMN1; SMN2 (0.61) SMN1; SMN2L3MBTL1ALDH1A1KDM4ELMNA
SCHEMBL1070289 0.80 SMN1; SMN2 (0.55) SMN1; SMN2L3MBTL1ALDH1A1KDM4ELMNA
SCHEMBL1067810 0.80 SMN1; SMN2 (0.55) SMN1; SMN2L3MBTL1ALDH1A1KDM4ELMNA
SCHEMBL1068543 0.79 SMN1; SMN2 (0.54) SMN1; SMN2L3MBTL1ALDH1A1KDM4ELMNA
SCHEMBL7762856 0.77 TNKS2 (0.43) SMN1; SMN2L3MBTL1LMNATP53
SCHEMBL11277506 0.76 SMN1; SMN2 (0.59) SMN1; SMN2L3MBTL1ALDH1A1KDM4ELMNA
SCHEMBL16915719 0.73 SMN1; SMN2 (0.41) SMN1; SMN2L3MBTL1LMNATP53ACHE
SCHEMBL1992827 0.72 L3MBTL1 (0.47) SMN1; SMN2L3MBTL1ALDH1A1KDM4ELMNA
SCHEMBL1990556 0.68 SMN1; SMN2 (0.50) SMN1; SMN2L3MBTL1ALDH1A1KDM4ELMNA
SCHEMBL30015888 0.68 SMN1; SMN2 (0.46) SMN1; SMN2L3MBTL1ALDH1A1LMNATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110152243-A1 NOVEL THIENOPYRROLE COMPOUNDS ABBOTT LABORATORIES (US) 2011-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110152243-A1 NOVEL THIENOPYRROLE COMPOUNDS TPMT, TSLP, THPO SMN1; SMN2 2548/4885L3MBTL1 3898/4885ALDH1A1 297/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.